Human factor IX corrects the bleeding diathesis of mice with hemophilia B

Blood

Volumn 91, Issue 3, 1998, Pages 784-790

  Kung, Szu Hao ^b   Hagstrom, J N ^b   Cass, Darrell ^b   Tai, Shing Jen ^b   Lin, Hui Feng ^b   Stafford, Darrel W ^b   High, Katherine A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9 CONCENTRATE;

ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BLEEDING TENDENCY; BLEEDING TIME; BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD COMPONENT THERAPY; CONTROLLED STUDY; HEMATOLOGICAL PARAMETERS; HEMOPHILIA; HEMOPHILIA B; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032005213     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.3.784.784_784_790     Document Type: Article

References (30)

1. Lin HF, Maeda N, Smithies O, Straight DL, Stafford DW: A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90:3962, 1997
2. Kadish JL, Wenc KM, Dvorak HF: Tissue factor activity of normal and neoplastic cells: Quantitation and species specificity. J Nat Cancer Inst 70:551, 1983
3. Fang CH, Lin TC, Guha A, Nemerson Y, Konigsberg WH: Activation of factor X by factor VIIa complexed with human-mouse tissue factor chimeras requires human exon 3. Thromb Haemost 76:361, 1996
4. Walter J, You Q, Hagstrom JN, Sands M, High KA: Successful expression of human factor IX following repeat administration of adenoviral vector in mice. Proc Nat Acad Sci USA 93:3056, 1996
5. Berkner KL, Sharp PA: Generation of adenovirus by transfection of plasmids. Nucleic Acids Res 11:6003, 1983
6. Herzog RW, Hagstrom JN, Kung SH, Tai SJ, Wilson JM, Fisher KJ, High KA: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Nat Acad Sci USA 94:5804, 1997
7. Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, Fratantoni J, Green D, Hampton J, Hilgartner M, Levine P, Lazerson J, McMillan C, Penner J, Shapiro S, Shulman NR: Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 34:612, 1975
8. Vu TK, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057, 1991
9. Altieri DC: Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa. J Biol Chem 269:3139, 1994
10. Cheung WF, van den Born J, Kuhn K, Kjellen L, Hudson BG, Stafford DW: Identification of the endothelial cell binding site for factor IX. Proc Nat Acad Sci USA 93:11068, 1996
11. Ahmad SS, Rawala-Sheikh R, Cheung WF, Jameson BA, Stafford DW, Walsh PN: High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11. Biochemistry 33:12048, 1994
12. Smith KJ, Thompson AR: Labeled factor IX kinetics in patients with hemophilia-B. Blood 58:625, 1981
13. Thompson AR, Forrey AW, Gentry PA, Smith KJ, Harker LA: Human factor IX in animals: Kinetics from isolated, radiolabelled protein and platelet destruction following crude concentrate infusions. Br J Haematol 45:329, 1980
14. Dejana E, Quintana A, Callioni A, de Gaetano G: Bleeding time in laboratory animals. III-Do tail bleeding times in rats only measure a platelet defect? (the aspirin puzzle). Thromb Res 15:199, 1979
15. Dejana E, Callioni A, Quintana A, de Gaetano G: Bleeding time in laboratory animals. II-A comparison of different assay conditions in rats. Thromb Res 15:191, 1979
16. Diness V, Lund-Hansen T, Hedner U: Effect of recombinant human FVIIA on warfarin-induced bleeding in rats. Thromb Res 59:921, 1990
17. Gailani D, Lasky NM, Broze GJ: A murine model of factor XI deficiency. Blood 88:469a, 1996 (abstr, suppl 1)
18. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr: Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A [letter]. Nature Genet 10:119, 1995
19. Green PM, Montandon AJ, Ljung R, Bentley DR, Nilsson IM, Kling S, Giannelli F: Haemophilia B mutations in a complete Swedish population sample: A test of new strategy for the genetic counselling of diseases with high mutational heterogeneity. Br J Haematol 78:390, 1991
20. Matthews RJ, Anson DS, Peake IR, Bloom AL: Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients. J Clin Invest 79:746, 1987
21. Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M: Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet 5:397, 1993
22. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet 16:270, 1997
23. Guo ZS, Wang LH, Eisensmith RC, Woo SL: Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther 3:802, 1996
24. Bi L, Sarkar R, Naas T, Lawler AM, Pain J, Shumaker SL, Bedian V, Kazazian HH Jr: Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 88:3446, 1996
25. van Dieijen G, Tans G, Rosing J, Hemker HC: The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 256:3433, 1981
26. Hoffman M, Monroe DM, Roberts HR: Cellular interactions in hemostasis. Haemostasis 26:12, 1996
27. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle JS, Fang B, Bellinger D, Finegold M, Thompson AR, Read M, Brinkhous KM, Woo SLC: In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Nat Acad Sci USA 91:2353, 1994
28. Wu S-M, Stafford DW, Ware J: Deduced amino acid sequence of mouse blood-coagulation factor IX. Gene 86:275, 1990
29. Giannelli F, Green PM, Sommer SS, Poon MC, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG: Haemophilia B: Database of point mutations and short additions and deletions, 7th edition. Nucleic Acids Res 25:133, 1997
30. Barr D, Tubb J, Ferguson D, Scaria A, Lieber A, Wilson C, Perkins J, Kay MA: Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Therapy 2:151, 1995